/Companies

Alloy Therapeutics, Inc.

also invests · investor profile

Waltham, US · Founded 2020 · Delaware corporation · 9 known investors

Find your way into Alloy Therapeutics, Inc.

516 people in our graph can introduce you to the Alloy Therapeutics, Inc. team.

Sign up to see every warm intro you have to Alloy Therapeutics, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alloy Therapeutics, Inc. team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.

Founders & leadership

Alloy Therapeutics, Inc. was founded in 2020 by Errik B. Anderson.

EBErrik B. Anderson
Errik B. AndersonFounderExecutive Officer and Director at Alloy Therapeutics, a venture studio that creates and develops early-stage drug discovery companies in partnership with academics, entrepreneurs, and pharmaceutical firms.
PBPiotr Bobrowicz
Piotr BobrowiczExecutivePiotr Bobrowicz is an Executive Officer and Director at Alloy Therapeutics, where he works on translational science and the development of discovery technologies for biotech companies and academic researchers. He has expertise in bridging biologics discovery platforms with drug development.
JRJay Rosanelli
Jay RosanelliExecutive

Board

AS
Anthony SunBoard director
AH
Alaa HalawaBoard directorGeneral Partner at MC Healthcare Ventures
UNUlrik Nielsen
Ulrik NielsenBoard directorGeneral Partner at Mission Biocapital
JC
Jason CammBoard director
CK
Christian KanadyBoard director
AKAlex Kolicich
Alex KolicichBoard directorInvestment Team at 8VC
LS
Logan SnyderBoard director
FH
Fabian HansenBoard director
JC
Jason ColomaBoard director

Investors · 9

Funding

SEC filings, press & company announcements

$186.8M disclosed across 4 rounds · 2021–2026

▶$30MraisedApr 2026 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony SunDirector
  • Alaa HalawaDirector
  • Ulrik NielsenDirector
  • Jason CammDirector
  • Jason ColomaDirector
  • Christian KanadyDirector
  • Alex KolicichDirector
  • Errik B. AndersonExecutive Officer, Director
  • Piotr BobrowiczExecutive Officer, Director
  • Logan SnyderDirector
Offering amount
$40M
Amount sold
$30M
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$41.7MraisedOct 2022 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony SunDirector
  • Alaa HalawaDirector
  • Ulrik NielsenDirector
  • Piotr BobrowiczExecutive Officer, Director
  • Jason CammDirector
  • Errik B. AndersonExecutive Officer, Director
  • Logan SnyderExecutive Officer, Director
  • Fabian HansenDirector
  • Alex KolicichDirector
  • Jason ColomaDirector
Offering amount
$41.7M
Amount sold
$41.7M
Proceeds to insiders
$1M
First sale
Sep 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$75MraisedApr 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Piotr BobrowiczExecutive Officer, Director
  • Ulrik NielsenDirector
  • Jay RosanelliExecutive Officer
  • Jason ColomaDirector
  • Errik B. AndersonExecutive Officer, Director
  • Fabian HansenDirector
  • Jason CammDirector
  • Alex KolicichDirector
  • Logan SnyderExecutive Officer, Director
Offering amount
$75M
Amount sold
$75M
Proceeds to insiders
$1M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Alloy Therapeutics, Inc. went on to found or lead other companies.

Frequently asked questions

What does Alloy Therapeutics, Inc. do?
A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.
Who founded Alloy Therapeutics, Inc.?
Alloy Therapeutics, Inc. was founded by Errik B. Anderson in 2020.
Who are Alloy Therapeutics, Inc.'s investors?
Alloy Therapeutics, Inc.'s investors include 82VS, 8VC, Alumni Ventures, Germin8 Ventures, JIC Venture Growth Investments, Presight Capital, Gaingels, MC Healthcare Ventures and 1 more.
How much funding has Alloy Therapeutics, Inc. raised?
Alloy Therapeutics, Inc. has disclosed $186.8M raised across 4 rounds.
Where is Alloy Therapeutics, Inc. headquartered?
Alloy Therapeutics, Inc. is headquartered in Waltham, US.